Institutional investors and medical innovation
Year of publication: |
2019
|
---|---|
Authors: | Unsal, Omer ; Rayfield, Blake |
Published in: |
The quarterly review of economics and finance : journal of the Midwest Economics Association ; journal of the Midwest Finance Association. - Amsterdam [u.a.] : Elsevier, ISSN 1062-9769, ZDB-ID 1114217-0. - Vol. 74.2019, p. 190-205
|
Subject: | Firm innovation | Institutional ownership | Pharmaceuticals | Institutioneller Investor | Institutional investor | Innovation | Pharmaindustrie | Pharmaceutical industry | Arzneimittel | Industrieforschung | Industrial research |
-
How does basic research improve innovation performance in the world's major pharmaceutical firms?
Leten, Bart, (2022)
-
The impact of the entry of biosimilars : evidence from Europe
Scott Morton, Fiona, (2017)
-
Fan, Jianting, (2022)
- More ...
-
Institutional monitoring and litigation risk : Evidence from employee disputes
Rayfield, Blake, (2021)
-
Product recalls, lobbying, and firm value
Rayfield, Blake, (2019)
-
Do overconfident CEOs stay out of trouble? Evidence from employee litigations
Rayfield, Blake, (2019)
- More ...